HIGHLIGHTS
- who: Levine and collaborators from the Paracelsus Medical University, Austria have published the Article: Beth Levine s Legacy: From the Discovery of BECN1 to Therapies. A Mentees Perspective, in the Journal: (JOURNAL)
- what: Altogether, these studies show that an increment in autophagy levels in mammals can delay aging and age-related alterations and constitute a proof of concept enlightening the major focus of Beth Levine's lab: the potential of autophagy stimulation in counteracting different pathological disorders.
SUMMARY
Similar to Atg6, BECN1 was then found to be a part of Class . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.